Inspire Medical Systems, INC 10-Q quarterly reports

Inspire Medical Systems announced Q2 2026 results showing a revenue decrease driven by U.S. market challenges, while also detailing ongoing legal proceedings and a new strategic growth plan.

Inspire Medical Systems reported a 1.6% revenue increase for Q1 2026, but a significant net loss driven by tax impacts and operational expenses.

Inspire Medical Systems reported a 46.3% drop in Q3 net income to $9.9 million despite a 10.5% revenue increase, as new product launch delays and GLP-1 drug impacts weigh on performance.

Inspire Medical Systems reported a net loss in Q2 2025, despite revenue growth, as increased operating expenses and new product transition challenges impacted profitability.

Inspire Medical Systems reports a 22.7% increase in revenue for Q1 2025, reaching $201.3 million, and achieves net income of $3.0 million.

Inspire Medical Systems reported a significant increase in revenue and a return to profitability in the third quarter of 2024, driven by strong sales growth in the U.S. and international markets.

Inspire Medical Systems reports a strong second quarter with a 29.6% increase in revenue year-over-year, reaching $195.9 million, and a net income of $9.8 million.

Inspire Medical Systems saw a 28.2% increase in revenue in the first quarter of 2024, reaching $164 million, while managing ongoing supply chain issues and expanding its market presence.